Stock ELV ELEVANCE HEALTH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Elevance Health, Inc.

Equities

ELV

US0367521038

Managed Healthcare

Real-time Estimate Cboe BZX
Other stock markets
 10:26:11 30/04/2024 pm IST 		5-day change 1st Jan Change
528.9 USD -0.96% Intraday chart for Elevance Health, Inc. -0.92% +11.97%
26/04 HCA beats first-quarter profit estimates on higher patient admissions RE
25/04 Elevance Health Insider Sold Shares Worth $10,832,155, According to a Recent SEC Filing MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 76,584 79,856 1,12,508 1,22,511 1,10,797 1,24,106 - -
Enterprise Value (EV) 1 92,083 94,150 1,30,384 1,39,238 1,29,391 1,41,293 1,36,838 1,35,712
P/E ratio 16.4 x 17.9 x 18.7 x 20.7 x 18.7 x 15.5 x 13.6 x 12.1 x
Yield 1.06% 1.18% 0.98% 1% 1.26% 1.17% 1.26% 1.36%
Capitalization / Revenue 0.74 x 0.66 x 0.82 x 0.79 x 0.65 x 0.72 x 0.68 x 0.64 x
EV / Revenue 0.89 x 0.78 x 0.95 x 0.89 x 0.76 x 0.82 x 0.75 x 0.7 x
EV / EBITDA 11.7 x 10.1 x 13 x 12.7 x 10.7 x 10.5 x 9.3 x 8.44 x
EV / FCF 18.5 x 9.74 x 17.9 x 19.2 x 19.1 x 16.8 x 14.1 x 13 x
FCF Yield 5.41% 10.3% 5.58% 5.2% 5.23% 5.94% 7.09% 7.71%
Price to Book 2.48 x 2.46 x 3.17 x 3.36 x 2.85 x 2.81 x 2.47 x 2.16 x
Nbr of stocks (in thousands) 2,53,564 2,48,704 2,42,715 2,38,828 2,34,959 2,32,418 - -
Reference price 2 302.0 321.1 463.5 513.0 471.6 534.0 534.0 534.0
Announcement Date 29/01/20 27/01/21 26/01/22 25/01/23 24/01/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,03,141 1,20,808 1,36,943 1,55,660 1,70,209 1,71,565 1,82,376 1,95,087
EBITDA 1 7,862 9,320 10,011 10,924 12,114 13,490 14,708 16,073
EBIT 1 7,067 8,527 9,150 10,016 11,254 12,362 13,447 14,729
Operating Margin 6.85% 7.06% 6.68% 6.43% 6.61% 7.21% 7.37% 7.55%
Earnings before Tax (EBT) 1 5,985 6,238 7,925 7,769 7,715 10,457 11,751 12,657
Net income 1 4,807 4,572 6,104 6,025 5,987 8,042 9,058 9,979
Net margin 4.66% 3.78% 4.46% 3.87% 3.52% 4.69% 4.97% 5.12%
EPS 2 18.47 17.98 24.73 24.81 25.22 34.44 39.33 44.18
Free Cash Flow 1 4,984 9,667 7,277 7,247 6,765 8,398 9,695 10,462
FCF margin 4.83% 8% 5.31% 4.66% 3.97% 4.9% 5.32% 5.36%
FCF Conversion (EBITDA) 63.39% 103.72% 72.69% 66.34% 55.84% 62.25% 65.92% 65.09%
FCF Conversion (Net income) 103.68% 211.44% 119.22% 120.28% 112.99% 104.43% 107.04% 104.84%
Dividend per Share 2 3.200 3.800 4.520 5.120 5.920 6.254 6.720 7.251
Announcement Date 29/01/20 27/01/21 26/01/22 25/01/23 24/01/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 36,018 37,886 38,482 39,625 39,667 41,898 43,377 42,480 42,454 42,273 42,906 42,849 43,446 44,506 45,752
EBITDA 1 1,998 3,046 2,993 2,862 2,023 3,472 3,313 3,659 2,094 3,746 3,534 3,568 2,493 3,985 4,028
EBIT 1 1,773 2,817 2,766 2,636 1,797 3,245 3,101 3,021 1,887 3,531 3,293 3,288 2,250 3,866 3,697
Operating Margin 4.92% 7.44% 7.19% 6.65% 4.53% 7.74% 7.15% 7.11% 4.44% 8.35% 7.68% 7.67% 5.18% 8.69% 8.08%
Earnings before Tax (EBT) 1 1,400 2,326 2,143 2,146 1,154 2,619 2,441 1,654 1,001 2,939 2,860 2,835 1,908 3,429 3,342
Net income 1 1,137 1,805 1,653 1,618 949 1,989 1,853 1,289 856 2,246 2,204 2,169 1,482 2,647 2,524
Net margin 3.16% 4.76% 4.3% 4.08% 2.39% 4.75% 4.27% 3.03% 2.02% 5.31% 5.14% 5.06% 3.41% 5.95% 5.52%
EPS 2 4.630 7.390 6.790 6.680 3.930 8.300 7.790 5.450 3.630 9.590 9.452 9.287 6.404 11.49 10.90
Dividend per Share 2 1.130 1.280 1.280 1.280 1.280 1.480 1.480 1.480 1.480 1.630 1.525 1.525 1.525 1.557 1.557
Announcement Date 26/01/22 20/04/22 20/07/22 19/10/22 25/01/23 19/04/23 19/07/23 18/10/23 24/01/24 18/04/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 15,499 14,294 17,876 16,727 18,594 17,187 12,731 11,605
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.971 x 1.534 x 1.786 x 1.531 x 1.535 x 1.274 x 0.8656 x 0.7221 x
Free Cash Flow 1 4,984 9,667 7,277 7,247 6,765 8,398 9,695 10,462
ROE (net income / shareholders' equity) 16% 14.1% 17.6% 16.7% 20.8% 20.7% 20.3% 17.6%
ROA (Net income/ Total Assets) 6.45% 5.57% 6.64% 6.02% 7.43% 7.96% 8.09% 7.84%
Assets 1 74,512 82,034 91,962 1,00,116 80,538 1,01,033 1,12,014 1,27,321
Book Value Per Share 2 122.0 131.0 146.0 153.0 166.0 190.0 216.0 247.0
Cash Flow per Share 2 23.30 42.00 33.90 34.60 34.00 37.00 43.90 -
Capex 1 1,077 1,021 1,087 1,152 1,296 1,353 1,395 1,463
Capex / Sales 1.04% 0.85% 0.79% 0.74% 0.76% 0.79% 0.76% 0.75%
Announcement Date 29/01/20 27/01/21 26/01/22 25/01/23 24/01/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Elevance Health, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
534 USD
Average target price
599.5 USD
Spread / Average Target
+12.27%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Managed Healthcare

1st Jan change Capi.
ELEVANCE HEALTH, INC. Stock Elevance Health, Inc.
+11.97% 124B
UNITEDHEALTH GROUP INC. Stock UnitedHealth Group Inc.
-8.22% 450B
CIGNA Stock Cigna
+18.97% 101B
CENTENE CORPORATION Stock Centene Corporation
-1.16% 39.4B
HUMANA INC. Stock Humana Inc.
-33.42% 36.53B
MOLINA HEALTHCARE, INC. Stock Molina Healthcare, Inc.
-5.86% 20.15B
PROGYNY, INC. Stock Progyny, Inc.
-12.48% 3.13B
ALIGNMENT HEALTHCARE, INC. Stock Alignment Healthcare, Inc.
-40.65% 969M
CLOVER HEALTH INVESTMENTS, CORP. Stock Clover Health Investments, Corp.
-32.06% 334M
Other Managed Healthcare
  1. Stock Market
  2. Equities
  3. ELV Stock
  4. Financials Elevance Health, Inc.